Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc > Zypitamag sales continues to accelerate

<< Previous

Bullboard Posts

Next >>

Comment by Winnipeg40on Jun 02, 2022 11:42am

377 Views

Post# 34726663

RE:RE:RE:Zypitamag sales continues to accelerate

The CEO doesnt seem to know that when you are in breach of a material obligation, it must be disclosed in clear language in the Financial Statements and MD+A and SEC Filings. Investors shouldnt have to glean this information from what is NOT in the financial statements. Look out ff the Securities Commission comes after them for non-disclosure. Would be lights out!

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals